2013 American Transplant Congress
Liver May Not Protect Against Kidney Rejection in Simultaneous Liver-Kidney Transplantation (SLK), The
Northwestern University Feinberg School of Medicine, Chicago, IL
Introduction: Due to the parallel liver transplant, SLK recipients are thought to be protected from kidney rejection and receive similar immunosuppression (IS) as liver transplant…2013 American Transplant Congress
Worldwide Survey of Live Liver Donor Evaluations
Background: Evaluation protocols for living liver donors candidates (LDCs) are not standardized. We conducted a worldwide survey of LDLT programs to determine current practices for…2013 American Transplant Congress
Back to Bladder Drained Pancreas Transplantation Alone: A Single Centre Experience
Controversy remains whether there is still a role for bladder drainage (BD) in pancreas transplantation. Compared to excellent results in simultaneous pancreas kidney transplantation, pancreas…2013 American Transplant Congress
ABO-Incompatible Kidney Transplantation Protects the Graft from Natural Antibodies Induced Damage and Prevents Immune Responses to Donor HLA and Kidney Associated Self Antigens Leading to Long Term Rejection Free Survival
Washington University, St. Louis, MO
Background: There is increased interest in ABO-incompatible (ABOi) kidney transplantation (KTx) worldwide. With appropriate selection based on anti-ABO titer, reduction of natural antibodies (NAbs) by…2013 American Transplant Congress
Determinants of Medication Misunderstanding and Non-Adherence among Kidney and Liver Transplant Recipients
OBJECTIVE: The study objective was to determine the prevalence and risk factors for medication non-nadherence and misunderstanding among solid organ transplant (SOT) recipients; and examine…2013 American Transplant Congress
Phenotype and Functionality of BKV-Specific T Cells Are Differently Affected by Distinct Immunosuppressive Drugs
Background: Immunosuppression of kidney allograft recipients is currently the indispensable method to avoid graft rejection. Nevertheless, suppression of the cellular immunity is an important risk…2013 American Transplant Congress
Recurrence of Focal Segmental Glomerulosclerosis after Renal Transplantation: Who Benefits from Preemptive Plasmapheresis?
BACKGROUND: Post-transplant recurrence of primary focal segmental glomerulosclerosis (FSGS) has been attributed to a persistent circulating permeability factor. Prophylactic peri-operative plasmapheresis (PP) has been used…2013 American Transplant Congress
Predicting Patient Survival after Kidney Transplantation (KTx): The First Year and Beyond
Nephrology and Transplantation, Mayo Clinic, Rochester, MN
Introduction: An important goal of pre-transplant evaluation is to identify candidates at risk for cardiovascular (CV) events and mortality post-transplant. Current approaches for risk assessment…2013 American Transplant Congress
Rituximab or Alemtuzumab Induction for ABO Incompatible Renal Transplantation?
Imperial College Renal and Transplant Centre, Hammersmith Hospital, London, United Kingdom
ABO incompatible [ABOi] live-donor renal transplantation is a successful and accepted form of treatment for patients with end stage renal failure. Most antibody removal protocols…2013 American Transplant Congress
Utilization of Compatible Pairs in a Large Kidney Paired Donation Program
Background: Our center has established a very large single center kidney paired donation (KPD) program. A significant barrier to KPD transplant has been the unbalanced…
American Transplant Congress abstracts